S100A8 and Sepsis: Fan Su et al. demonstrated that a nanocomplex loaded with the S100A8/9 inhibitor ABR2527 effectively blocked neutrophil-S100A8/9-toll-like receptor (TLRS)-inflammatory vesicle signalling, thereby attenuating sepsis-induced acute lung injury in preclinical mice (Su et al., 2025).